Diabetes Clinical Trials in Phoenix

Showing 261-280 of 484 trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

NCT01013766

This study is the second administration of GSK1362885 in humans. GSK1362885 is a novel, potent inhibitor of human glycogen phosphorylase (GP) under development for the treatment of type 2 diabetes mellitus (T2DM). This study will investigate the compound's safety, tolerability, pharmacokinetics, and pharmacodynamics in subjects with Type 2 Diabetes Mellitus.

Diabetes Mellitus, Type 2

GlaxoSmithKline23 participantsStarted Aug 2009

Phoenix, Arizona, United States • Saint Paul, Minnesota, United States

COMPLETEDPhase 3< 1 mile

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

NCT02298192

This trial is conducted in Europe, North America and the United States of America. The aim of this trial is to compare two different titration algorithms of insulin degludec/liraglutide.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S420 participantsStarted Nov 2014

Hamilton, Alabama, United States • Chandler, Arizona, United States • Glendale, Arizona, United States +81 more locations

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Diabetes Trials in Other Cities

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus

Study In People With Type 2 Diabetes

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

Thiazolidinedione Intervention With Vitamin D Evaluation

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

A Study of LY2405319 in Participants With Type 2 Diabetes

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes

Other Conditions in Phoenix